Download curriculum vitae - Expert Witness Network

CURRICULUM VITAE
PERSONAL
Name:
Office Address:
Business Phone:
Place of Birth:
Abram Charles Rabinowitz, M.D.
4330 Medical Drive, Suite 500, San Antonio, Texas 78229
(210) 692-1414
Corpus Christi, Texas
EDUCATION
College:
Rice University, 1967-1971 Degree: B.A.
Medical:
UTSA School of Medicine, San Antonio
Post-Graduate:
1975/76
1976/78
1978/79
1979/80
1980/81
Degree: M.D., 1975
INTERNSHIP Univ of WA Medical School, Seattle
RESIDENCY Univ of WA Medical School, Internal
Medicine
CHIEF RESIDENT Univ of WA Medical School, Int. Med.
FIRST YEAR FELLOW Univ of WA Med School,
Cardiology and Cardiovascular Diseases
FELLOW UTSA School of Medicine, San Antonio,
Cardiology and Cardiovascular Diseases
ACADEMIC AND CURRENT POSITIONS
1981 - Present
1983 - 1984
1987
1993 - Present
1996 - Present
2000 - Present
2003 – Present
2004
Private Practice: Cardiovascular Diseases, San Antonio, Texas
Clinical Assistant Professor: Department of Medicine, Division of
Cardiology, University of Texas School of Medicine, San Antonio
Research in Doppler Echoardiography, UTSA School of Medicine
Clinical Faculty: Clinical Forum, Stanford School of Medicine, Division
of Cardiology
Faculty: Advances in PTCA and Laser Angioplasty, Baylor Hospital,
Dallas, Texas
CEO, South Texas Cardiovascular Center and Catheterization Laboratory
Managing Partner, South Texas Cardiovascular Consultants (14 physician
single specialty cardiovascular practice)
Chairman of the Board, TexSAn Heart Hospital, San Antonio, Texas
Editorial Board, the American Heart Hospital Journal
Faculty: Featured Speaker Texas Academy of Family Practice annual
1
Abram Charles Rabinowitz, MD, FACC FACP FSCAI FAHA
Curriculum Vitae
education updates, Austin, Texas.
2004 – 2006 Faculty: Primary Care Updates CME Series, University of Nevada Medical
School – Quintiles Continuing Medical Education Seminars – “Treatment
of Hyperlipidemia in the High Risk Patient”
2005 – 2006
Faculty: Symposium Series: “Evidenced Based Medicine: A Guide to
Clinical Practice” Johns Hopkins University School of Medicine
2006 – Present
Fellow, Round Table Group – think tank of academicians and recognized
experts and lecturers.
2006-Present
Member, Healthcare Litigation Support
HONORS
Alpha Omega Alpha (Medical Honor Society)
Fellow of the American College of Physicians 1986
Fellow of the American College of Cardiology 1986
Fellow of the American Heart Association (Clinical Council)
Fellow of the American College of Chest Physicians
Fellow of the Society for Cardiac Angiography and Interventions
Fellow of the American Society of Angiology
Selected by Consumer’s Research Council for inclusion in AGuide to
America’s Top Physicians each year 2001 to 2006
Selected by Texas Monthly Magazine for inclusion in December, 2004, 2005
and
2006 article “Texas Super Doctors.”
MEDICAL SOCIETIES AND ASSOCIATIONS MEMBERSHIPS
(1980 - Present)
American Medical Association
Texas Medical Association
Kendall County Medical Society
Texas Society of Internal Medicine
American Society of Internal Medicine
American College of Physicians
American College of Cardiology (1981 - Present)
American Heart Association
AHA Council on Clinical Cardiology
AHA Council on Cardiovascular Radiology & Intervention
AHA Council on Arterioscleroses & Thrombosis
San Antonio Heart Association
2
Abram Charles Rabinowitz, MD, FACC FACP FSCAI FAHA
Curriculum Vitae
CLINICAL INVESTIGATIONS CONDUCTED BY SOUTH TEXAS
CARDIOVASCULAR CONSULTANTS CLINICAL RESEARCH CENTER
Trials Currently Enrolling or in Followup Phase
Principal Investigator
Principal Investigator
Principal Investigator
Co-Principal Investigator
MEND-CABG
AMETHYST (Safety and Efficacy of “Interceptor” device for embolic protection in
de novo and restenotic SVG lesions, phase I and II)
COSTAR II (CObalt chromium STent with Antiproliferative for Restenosis)
EARLY ACS (Early front loaded Eptifibatide in the treatment of Acute Coronary
Syndrome)
Co-Principal Investigator
Co-Principal Investigator
Principal Investigator
Co-Principal Investigator
Principal Investigator
Principal Investigator
Principal Investigator
Principal Investigator
Co-Principal Investigator
Principal Investigator
Principal Investigator
Principal Investigator
Co-Principal Investigator
ASSERT (ASymptomatic AF and Stroke Evaluation in Pacemaker patients and the
AF Reduction Atrial Pacing Trial)
RELY (Randomized Evaluation of Long Term Anticoagulant Therapy) comparing
open label wafarin vs. dabigatran etexilate
ARRIVE (TAXUS drug eluting stent multi-center safety surveillance study)
TRITON TIMI 38 (Prasugrel vs. Clopidogrel in ACS)
MICRODRIVER (cobalt chromium stent, phase II)
OASIS-5 (RCT comparing fondaparinux with enoxaparin in
ACS)
DELIVER (A Randomized Comparison of Paclitaxel-Coated Versus Metallic Stents
for Treatment of Coronary Lesions )
PROTECT - TIMI 30 (A Randomized Trial to Evaluate the Relative Protection
Against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia Among AntiPlatelet and Anti-Thrombotic Agents)
ACTIVE (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of
Vascular Events)
MEDTRONIC S8 stent trial
PEECH (Prospective Evaluation of EECP in Heart Failure)
TcN-NoET
PEACE (Prevention of Events with Angiotensin-Converting Enzyme Inhibitor
Therapy)
Principal Investigator
Co-Principal Investigator
ENDEAVOR III (Randomized Controlled Trial Medtronic
Endeavor ABT-578 Drug Eluting Stent)
CREDO (Randomized Comparison Between Two Different Clopidogrel Maintenance
Co-Principal Investigator
Doses After Percutaneous Coronary Intervention)
EPHESIUS (Eplerenone in patients with heart failure due to systolic dysfunction
complicating acute myocardial infarction)
Co-Principal Investigator
Co-Principal Investigator
Co-Principal Investigator
Co-Principal Investigator
Co-Principal Investigator
SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)
VALIANT (VALsartan In Acute myocardial iNfarcTion trial)
ESPRIT (Eptifibatide in Percutaneous Coronary Intervention)
INVEST (Internatioinal Verapamil SR and Trandolapril Study)
AMISTAD II (Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to
Evaluate the Efficacy and Safety of Adenosine)
Co-Principal Investigator
Co-Principal Investigator
Co-Principal Investigator
STEP AMI (
PRINCE
PROVE-IT (Among patients with a recent acute coronary syndrome, does more
aggressive lipid lowering therapy (compared to standard therapy)
3
Abram Charles Rabinowitz, MD, FACC FACP FSCAI FAHA
Curriculum Vitae
Co-Principal Investigator
Co-Principal Investigator
Co-Principal Investigator
Co-Principal Investigator
LOGIC
A TO Z (Aggrastat to Zocor in the treatment of ACS)
QUASAR
CONVINCE (Controlled Onset Verapamil Investigation of Cardiovascular End
Points)
Co-Principal Investigator
Co-Principal Investigator
Co-Principal Investigator
Co-Principal Investigator
Co-Principal Investigator
Co-Principal Investigator
PARAGON-B (effect of optimal dosing of lamifiban (a platelet IIb/IIIa antagonist)
in combination with aspirin and heparin in patients with unstable angina or acute
myocardial infarction)
SYMPHONY (Sibrafiban versus aspirin to Yield Maximum Protection from
ischemic Heart events post-acute coronary syndromes)
MOXSE
MOXCON (Moxonidine in the Treatment of Congestive Heart Failure)
CROSSFLEX TAC
OPUS TIMI-16 (Orbofiban in Patients with Unstable coronary Syndromes)
MEDICAL BOARD STATUS
Board Certified:
Board Certified:
Board Certified:
American Board of Internal Medicine, Certificate #064999-9/78
American Board of Cardiovascular Diseases - 11/85
American Board of Internal Medicine, Added Qualifications in Interventional
Cardiology, 1999 through 2009, Certificate #64999
STATE LICENSES
Washington:
Texas:
DEA:
UPIN:
15433, 1976
E-8124, 1976
AR 9388934
C20759
PUBLICATIONS
1.
ECG Changes in the Athlete: Benign vs. Malignant, PRACTICAL CARDIOLOGY,
3/81*
2.
A Diagnostic Coding Scheme for Ambulatory Care Medicine, CLINICAL RESEARCH,
Vol XXIII, No 5, p.579.
3.
Advantage of Two-Dimensional Echo Over Radionuclide Angiography for Detecting
Acute Changes in LV Performance During Exercise, Circulation 64, Supplement IV,
p.13*.
4.
Left Ventricular Size and Performance During Maximal Exercise in Trained Athletes,
Circulation 64, Supplement IV, p.93.*
4
Abram Charles Rabinowitz, MD, FACC FACP FSCAI FAHA
Curriculum Vitae
5.
Prediction of Abnormal Exercise Response in Early Post-Myocardial Infarction Patients
by Non-Invasive Techniques, Circulation 64, Supplement IV, p.198.
6.
Effect of Isotonic Exercise Training on Left Ventricular Volume During Exercise,
Crawford, Michael H., Petru, Michael A., Rabinowitz, Charles. Circulation 72,
Supplement VI, December, 1985, peripheral pulses. 1237-1243.*
7.
Cardiac Tamponade from a Central Venous Catheter, Rabinowitz, A. Charles, Andrews,
Charles P. (In Press)
8.
Firt Multi-Center Experience with Novel, Low Profile Filter-Wire Distal Protection
Device (Interceptor) During Saphenous Vein Graft Stenting, Keriakes, D.J.,
Rabinowitz, A. C., et. al., Circulation supplement, 2002.
*Primary author is A. Charles Rabinowitz, M.D.
MISCELLANEOUS PROFESSIONAL EXPERIENCE
Research associate, Massachusetts General Hospital Computer Laboratory, 1974-1975.
Co-Arthur, COSTAR, Computerized Storage of Ambulatory Records, Harvard Community
Health Plan, 1975
Member, Clinical Affairs Committee, Bexar County Medical Foundation - 1983-1990
Medical Director and Director of Underwriting, Family Life Insurance Company, Seattle, WA
1978-1980.
Chairman, Cardiac Catheterization Equipment Committee, Southwest Texas Methodist Hospital,
1982.
Secretary, TMA Section of Internal Medicine, 1984/1985.
Chairman, TMA Section of Internal Medicine, 1985/1986.
Instructor, AHA "Advanced Cardiac Life Support" course, Southwest Texas Methodist Hospital
and Baptist Memorial Hospital, 1982 - present.
Faculty Instructor, training program for cardiac catheterization laboratory personnel - 1987-1988,
Southwest Texas Methodist Hospital.
Chief of Cardiology, St. Luke's Lutheran Hospital, 1986.
Chief of Cardiology, St. Luke's Lutheran Hospital, 1987.
Chief of Cardiology, Humana Hospital of San Antonio, 1986.
Chief of Cardiac Catheterization Laboratory, Southwest Texas Methodist Hospital, 1986.
Chairman of Utilization Review Committee, Southwest Texas Methodist Hospital, 1986.
Chairman of Utilization Review Committee, Southwest Texas Methodist Hospital, 1987.
Consultant, Cook Pacemaker Corporation, 1984/1986.
Quality Review Consultant, Texas Medical Foundation (PRO), 1986 - 2002
Chairman of Bioethics Committee, Southwest Texas Methodist Hospital, 1986/1987.
Chief of Staff, St. Luke's Lutheran Hospital, 1989.
Chairman, Ad-hoc Committee for laser application in cardiovascular disease, Southwest Texas
Methodist Hospital, 1987/1988.
Chairman, Critical Care Committee, Southwest Texas Methodist Hospital, 1990.
5
Abram Charles Rabinowitz, MD, FACC FACP FSCAI FAHA
Curriculum Vitae
Chairman, Pharmacy and Therapeutics Committee, Southwest Texas Methodist Hospital, 1991.
Chairman, Utilization Review and Quality Assurance Committee, Southwest Texas Methodist
Hospital, 1992
Deposition and Trial Testimony Experience
Coronary artery disease, coronary intervention, angioplasty, laser atherectomy, rotational
atherectomy, Congestive heart failure, Thrombolytic therapy, Chest pain, Delayed treatment,
Wrongful death, Medical devices, Patent infringement.
Training
16th Annual National Expert Witness Conference, Cape Cod, M
6
Abram Charles Rabinowitz, MD, FACC FACP FSCAI FAHA
Curriculum Vitae
7
Abram Charles Rabinowitz, MD, FACC FACP FSCAI FAHA
Curriculum Vitae
8
Abram Charles Rabinowitz, MD, FACC FACP FSCAI FAHA
Curriculum Vitae